Citadel Advisors’s Broadstone Acquisition Corp. BSN Stock Holding History

Citadel Advisors’s Portfolio BSN Stock Details BSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-575,844	Closed	-$5.73M	–	15416
2021 Q3	$5.73M	Sell	575,844 -222,027	-28%	-$2.19M	﹤0.01%	4048
2021 Q2	$7.88M	Sell	797,871 -88,009	-10%	-$867K	﹤0.01%	3525
2021 Q1	$8.67M	Buy	885,880 +235,880	+36%	+$2.38M	﹤0.01%	3198
2020 Q4	$6.53M	Buy	+650,000	New	+$6.38M	﹤0.01%	3229

Other funds holding BSN

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Citadel Advisors's BSN Position: Q4 2021 in Review

Citadel Advisors sold out of Broadstone Acquisition Corp. (BSN) in Q4 2021, closing a stake of 575,844 shares — an estimated $5.73M sold.

Citadel Advisors first reported a position in BSN in Q4 2020 and held it in 4 quarters. The position peaked at $8.67M in Q1 2021. 1 fund tracked by Wall St. Rank holds BSN as of Q4 2021.

Citadel Advisors reported no remaining Broadstone Acquisition Corp. position as of Q4 2021 after selling out during the quarter.
Citadel Advisors sold 575,844 Broadstone Acquisition Corp. shares in Q4 2021, an estimated $5.73M.
Citadel Advisors first reported a position in Broadstone Acquisition Corp. in Q4 2020 and held it in 4 quarters.
Citadel Advisors's Broadstone Acquisition Corp. position peaked at $8.67M in Q1 2021.
1 fund tracked by Wall St. Rank held Broadstone Acquisition Corp. as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.